Medical News

RSS

FDA proposed rules address industry, consumer concerns

The Food and Drug Administration may tighten rules for approving medical devices that are only slightly different from already-blessed products, The Chicago Tribune reports.

6 Aug 2010

IBM-Aetna partnership launches clinical support collaboration

IBM and Aetna have teamed up to create a service that will analyze patient medical records, claims data, lab results and other information to determine the best treatments, Reuters reports.

6 Aug 2010

State Department employees face 'stigma' for seeking mental health help

The State Department is attempting to change how it handles mental health services for employees with high-stress jobs, "but there's still a great deal of stigma attached to seeking this kind of help," an internal report says.

6 Aug 2010

Poor countries need assistance developing sustainable agricultural systems, USDA Undersecretary says

Governments and aid groups must do more to help the world's hungry develop sustainable agricultural systems, U.S. Agriculture Department Undersecretary James Miller said during an address Wednesday on the final day of the International Food Aid and Development Conference, the Associated Press reports (Hollingsworth, 8/4).

6 Aug 2010

Study uncovers leading causes of non-fatal injuries among older adults in China

Falls are the most common injury for both urban and rural elderly in China, responsible for more than two-thirds of all injuries in people 65 and older, according to a new study by researchers from China and the Johns Hopkins Bloomberg School of Public Health's Center for Injury Research and Policy. This is the first study to uncover the leading causes of non-fatal injuries among older adults in China, who make up 9 percent of the total population.

6 Aug 2010

JumpStart Ventures announces investment commitment of $250,000 in ChanRx

JumpStart Ventures, which invests in and partners with innovative, early-stage companies in Northeast Ohio, announced an investment commitment of $250,000 in drug development company ChanRx. The two-year-old company is developing a pharmaceutical compound to treat atrial fibrillation, a heart condition that affects two million Americans, with 200,000 new cases being diagnosed each year.

6 Aug 2010

ResMed revenue increases 16% to $291.6 million for quarter ended June 30, 2010

ResMed Inc. today announced record revenue and income for the quarter ended June 30, 2010, and a two-for-one stock split.

From ResMed Corp 6 Aug 2010

VA commits last of its Recovery Act funds to increase access to health care, services to Veterans

The Department of Veterans Affairs committed the last of its $1.8 billion in Recovery Act funds July 31, one of the first federal agencies to achieve that milestone. Projects at more than 1,200 sites in all 50 states, the District of Columbia and Puerto Rico will increase access to health care and services to Veterans, while creating jobs and stimulating the economy.

6 Aug 2010

Elsevier Properties congratulates Stewart for achieving Lectureship

Elsevier Properties SA is pleased to congratulate Dr. Scott Stewart on his winning the Royal Australian Chemical Institute's (RACI) 2010/11 Athel Beckwith Lectureship, sponsored by Reaxys.

6 Aug 2010

ViroPharma announces data on safety, efficacy of Cinryze to treat acute angioedema attacks

ViroPharma Incorporated today announced that data from Phase 3 studies of Cinryze (C1 esterase inhibitor [human]) have been published in the August 5, 2010 issue of the New England Journal of Medicine. The paper entitled Nanofiltered C1 Inhibitor Concentrate for Treatment of Hereditary Angioedema by Dr. Bruce L. Zuraw et al. describes the safety and efficacy of Cinryze in treating and preventing attacks of hereditary angioedema. Cinryze is the first and only FDA-approved C1 esterase inhibitor therapy indicated for routine prophylaxis against angioedema attacks in adolescent and adult patients with hereditary angioedema (HAE), a rare, debilitating and potentially fatal disease; it is not approved by the FDA to treat acute angioedema attacks.

6 Aug 2010

Norwegian cervical screening program begins reimbursing for liquid-based cytology

Hologic, Inc., a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, today announced that on July 1, 2010, the Norwegian cervical screening program began reimbursing for liquid-based cytology (LBC).

6 Aug 2010

Select Medical teams up with Baylor, joint venture to provide quality health care

Baylor Health Care System and Select Medical Corporation announced today a proposed partnership between Baylor Institute for Rehabilitation and a wholly-owned subsidiary of Select that is designed to create a regional rehabilitation network to serve the Dallas-Fort Worth metroplex. This joint venture is subject to governmental approvals and it is anticipated that the joint venture will be approved and finalized within the normal process for governmental review.

6 Aug 2010

UC Riverside scientists secure grants for tobacco control research

Tobacco-related disease kills more people worldwide than any other single factor. To help address this problem, the University of California, Riverside has received six grants from the University of California Tobacco-Related Disease Research Program (TRDRP), the most TRDRP grants the campus has received in any year.

6 Aug 2010

Accelrys revenues decline 2% to $19.8 million in second quarter

Accelrys, Inc. today reported financial results for the fiscal quarter ended June 30, 2010. Revenue for the quarter ended June 30, 2010 decreased 2% to $19.8 million from $20.1 million for the same quarter of the previous year.

6 Aug 2010

Conceptus second-quarter 2010 net sales increase 11.5% to $36.8 million

Conceptus, Inc., developer of the Essure procedure, the first proven non-surgical permanent birth control method available, today reported financial results for the three months ended June 30, 2010.

6 Aug 2010

Dermatologist discusses on common nail ailment prevention

For many people, the phrase "tough as nails" doesn't apply to their own nails. Instead of strong nails, their nails may be brittle and break or split easily. Or, nail fungus might cause nails to look unattractive and unhealthy. Fortunately, dermatologists can help people improve the health and overall appearance of their nails with proper diagnosis and treatment.

6 Aug 2010

Recession pushes cancer patients to forego treatment

In 2009 and 2010, as the economic collapse shuddered across the globe, oncologists in California noticed a troubling trend: Three patients who had had serious tumors under control for as long as eight years reappeared in the clinic with massive cancer regrowth which, in one case, required emergency surgery.

6 Aug 2010

AAHSA applauds Senate's passage of legislation on increasing Medicaid funding

The American Association of Homes and Services for the Aging applauds the Senate's passage of legislation to extend the temporary increase in federal Medicaid funding through June 30, 2011.

6 Aug 2010

Ingenix CareTracker practice management, EHR system available to Federally Qualified Health Centers

Ingenix, a leading health information technology and services company, today announced it is making a specially-designed version of its Ingenix CareTracker practice management and electronic health record system available to Federally Qualified Health Centers. Ingenix CareTracker, which provides all of the capabilities physicians need to demonstrate "Meaningful Use," will offer these community health centers a cost-effective, Web-based, practice management and EHR option that will help them improve operational efficiency and patient care, and qualify for incentives offered by the federal government for demonstrating Meaningful Use of health IT.

6 Aug 2010

Salamander research findings bring scientists closer to future regenerative therapies

Tissue regeneration in salamanders and newts seems like it should be the stuff of science fiction. But it happens routinely. Why can't we mammals just re-grow a limb or churn out a few new heart muscle cells as needed? New research suggests there might be a very good reason: Restricting our cells' ability to pop in and out of the cell cycle at will - a prerequisite for the cell division necessary to make new tissue - reduces the chances that they'll run amok and form potentially deadly cancers.

6 Aug 2010